- Zacks
Amarin (AMRN) Stock Down Despite Q2 Earnings & Revenues Beat
Amarin's (AMRN) second-quarter 2024 earnings and revenues beat estimates. Vascepa's sales in the United States decline year over year. Stock down.
- Motley Fool
Amarin Plc (AMRN) Q2 2024 Earnings Call Transcript
AMRN earnings call for the period ending June 30, 2024.
- InvestorPlace
3 Breakthrough Stocks Under $10 Set for Massive Upside
Uncovering affordable breakthrough stocks under $10 in the portfolio can lead to high-price return opportunities. Here, the focus is on three such stocks, each demonstrating strong fundamentals that signal high upside potential. The first company’s top prospects include continued revenue growth, significant improvements in gross margins and successful strategic expansions. These position the company for robust future performance in the environmentally sustainable carbon products sector. On the o
